(Q40559744)

21 September 2017

title

HCV core protein modulates the immune response against the HBV surface antigen in mice (English)

1 reference

21 September 2017

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

14 March 2024

2

Nelson Acosta-Rivero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511648

14 March 2024

author name string

Santiago Dueñas-Carrera

3

1 reference

21 September 2017

Juan Morales Grillo

4

1 reference

21 September 2017

Dagmara Pichardo

5

1 reference

21 September 2017

Dioslaida Urquiza

6

1 reference

21 September 2017

Gerardo Guillen

7

1 reference

21 September 2017

Verena Muzio

8

1 reference

21 September 2017

Julio C. Aguilar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511648

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511648

14 March 2024

publication date

1 October 2003

1 reference

21 September 2017

10 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511648

full work available at URL

14 March 2024

https://api.elsevier.com/content/article/PII:S0006291X0301742X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

https://api.elsevier.com/content/article/PII:S0006291X0301742X?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Biochemical and Biophysical Research Communications

14 March 2024

published in

1 reference

21 September 2017

volume

310

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

59-63

1 reference

A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin

21 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine

14 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines

14 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity

14 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Modern vaccines. Enteric infections

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

New strategies for using mucosal vaccination to achieve more effective immunization

14 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Mucosal immunogenicity of the hepatitis B core antigen

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

The human adenoid. A morphologic study

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

14 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

The injection century: massive unsterile injections and the emergence of human pathogens

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Hepatitis B infection among patients attending a sexually transmitted diseases clinic in Rio de Janeiro, Brazil

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Sequence analysis of the core gene of 14 hepatitis C virus genotypes

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Analysis of successful immune responses in persons infected with hepatitis C virus

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Neutralizing antiviral B cell responses

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

14 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.120

14 March 2024

Identifiers

1 reference

21 September 2017

1 reference